SRR1368856
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1468403 | GTEX | — | 0.949 |
| 2 | SRR1350525 | GTEX | — | 0.942 |
| 3 | SRR1387989 | GTEX | — | 0.939 |
| 4 | SRR1363633 | GTEX | — | 0.935 |
| 5 | SRR1446828 | GTEX | — | 0.923 |
| 6 | SRR1325401 | GTEX | — | 0.921 |
| 7 | SRR1488538 | GTEX | — | 0.913 |
| 8 | SRR612311 | GTEX | — | 0.907 |
| 9 | SRR615731 | GTEX | — | 0.902 |
| 10 | SRR819534 | GTEX | — | 0.901 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 31 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| CHOLESTEROL_HOMEOSTASIS | 0.547 | Remibrutinib | — uncovered |
| TNFA_SIGNALING_VIA_NFKB | 0.536 | Inavolisib | — uncovered |
| INFLAMMATORY_RESPONSE | 0.481 | Idelalisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.449 | Idelalisib | — uncovered |
| INTERFERON_ALPHA_RESPONSE | 0.446 | Inavolisib | — uncovered |
| ANGIOGENESIS | 0.439 | Remibrutinib | — uncovered |
| ALLOGRAFT_REJECTION | 0.432 | Idelalisib | — uncovered |
| IL2_STAT5_SIGNALING | 0.415 | Idelalisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.409 | Inavolisib | — uncovered |
| APOPTOSIS | 0.393 | Idelalisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.356 | Inavolisib | — uncovered |
| COAGULATION | 0.324 | Binimetinib | — uncovered |
| COMPLEMENT | 0.316 | Inavolisib | — uncovered |
| KRAS_SIGNALING_UP | 0.295 | Inavolisib | — uncovered |
| TGF_BETA_SIGNALING | 0.259 | Inavolisib | — uncovered |
| ANDROGEN_RESPONSE | 0.258 | Inavolisib | — uncovered |
| HYPOXIA | 0.256 | Idelalisib | — uncovered |
| P53_PATHWAY | 0.245 | Idelalisib | — uncovered |
| APICAL_SURFACE | 0.218 | Temsirolimus | — uncovered |
| MTORC1_SIGNALING | 0.206 | Inavolisib | — uncovered |